Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Exelixis Inc (NASDAQ: EXEL) closed the day trading at $43.62 down -1.03% from the previous closing price of $44.08. In other words, the price has decreased by -$1.03 from its previous closing price. On the day, 3.37 million shares were traded. EXEL stock price reached its highest trading level at $44.41 during the session, while it also had its lowest trading level at $43.315.
Ratios:
For a better understanding of EXEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.49. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On February 24, 2025, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight but kept the price unchanged to $36.
Morgan Stanley Upgraded its Equal-Weight to Overweight on January 27, 2025, whereas the target price for the stock was revised from $30 to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’25 when Eckhardt Sue Gail sold 18,838 shares for $42.74 per share. The transaction valued at 805,140 led to the insider holds 21,380 shares of the business.
WYSZOMIERSKI JACK L sold 7,535 shares of EXEL for $324,683 on Jun 03 ’25. The Director now owns 358,882 shares after completing the transaction at $43.09 per share. On Jun 03 ’25, another insider, JACK L WYSZOMIERSKI, who serves as the Director of the company, bought 7,535 shares for $43.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 11895522304 and an Enterprise Value of 11175426048. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.79, and their Forward P/E ratio for the next fiscal year is 13.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.17 while its Price-to-Book (P/B) ratio in mrq is 5.63. Its current Enterprise Value per Revenue stands at 4.861 whereas that against EBITDA is 13.237.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.28, which has changed by 0.98633885 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $21.82. The 50-Day Moving Average of the stock is 5.96%, while the 200-Day Moving Average is calculated to be 23.21%.
Shares Statistics:
Over the past 3-months, EXEL traded about 3.23M shares per day on average, while over the past 10 days, EXEL traded about 4561780 shares per day. A total of 275.03M shares are outstanding, with a floating share count of 263.89M. Insiders hold about 3.23% of the company’s shares, while institutions hold 92.61% stake in the company. Shares short for EXEL as of 1749772800 were 20385497 with a Short Ratio of 6.32, compared to 1747267200 on 18723325. Therefore, it implies a Short% of Shares Outstanding of 20385497 and a Short% of Float of 10.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
